Literature DB >> 19850927

Human IgG1 hinge fragmentation as the result of H2O2-mediated radical cleavage.

Boxu Yan1, Zac Yates, Alain Balland, Gerd R Kleemann.   

Abstract

Hinge cleavage of a recombinant human IgG1 antibody, generated during production in a Chinese hamster ovary cell culture, was observed in the purified material. The cleavage products could be reproduced by incubation of the antibody with H(2)O(2) and featured complementary ladders of the C- and N-terminal residues (Asp(226)-Lys(227)-Thr(228)-His(229)-Thr(230)) in the heavy chain of the Fab domain and the upper hinge of one of the Fc domains, respectively. Two adducts of +45 and +71 Da were also observed at the N-terminal residues of some Fc fragments and were identified as isocyanate and alpha-ketoacyl derivatives generated by radical cleavage at the alpha-carbon position through the diamide and alpha-amidation pathways. We determined that the hinge cleavage was initiated by radical-induced breakage of the disulfide bond between the two hinge cysteines at position 231 (Cys(231)-Pro-Pro-Cys-Pro), followed by the formation of a thiyl radical (Cys(231)-S(*)) on one cysteine and sulfenic acid (Cys(231)-SOH) on the other. The location of the initial radical attack and the critical role of Cys(231) were demonstrated by the observation that 5,5-dimethyl-1-pyrroline N-oxide only reacted with the Cys(231) radical and completely blocked hinge cleavage, suggesting the necessity of an electron/radical transfer from the Cys(231) radical to the hinge residues where cleavage was observed. As a precursor of hydroxyl radicals, H(2)O(2) is widely produced in healthy cells and tissues and therefore could be the source for the radical-induced fragmentation of human IgG1 antibodies in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850927      PMCID: PMC2790968          DOI: 10.1074/jbc.M109.064147

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Protein drug stability: a formulation challenge.

Authors:  Sven Frokjaer; Daniel E Otzen
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

Review 2.  Potent antibody therapeutics by design.

Authors:  Paul J Carter
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 3.  Downstream processing of monoclonal antibodies--application of platform approaches.

Authors:  Abhinav A Shukla; Brian Hubbard; Tim Tressel; Sam Guhan; Duncan Low
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-10-13       Impact factor: 3.205

Review 4.  Post-translational modifications in the context of therapeutic proteins.

Authors:  Gary Walsh; Roy Jefferis
Journal:  Nat Biotechnol       Date:  2006-10       Impact factor: 54.908

5.  Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage.

Authors:  Steven L Cohen; Colleen Price; Josef Vlasak
Journal:  J Am Chem Soc       Date:  2007-05-15       Impact factor: 15.419

Review 6.  TNF receptor superfamily-induced cell death: redox-dependent execution.

Authors:  Han-Ming Shen; Shazib Pervaiz
Journal:  FASEB J       Date:  2006-08       Impact factor: 5.191

7.  Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling.

Authors:  Garrett J DeYulia; Juan M Cárcamo; Oriana Bórquez-Ojeda; Christopher C Shelton; David W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

Review 8.  Antibody targeted drugs as cancer therapeutics.

Authors:  David Schrama; Ralph A Reisfeld; Jürgen C Becker
Journal:  Nat Rev Drug Discov       Date:  2006-02       Impact factor: 84.694

9.  Immunoglobulin light chains generate hydrogen peroxide.

Authors:  Pei-Xuan Wang; Paul W Sanders
Journal:  J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 10.121

Review 10.  Anti-infective monoclonal antibodies: perils and promise of development.

Authors:  Janice M Reichert; Matthew C Dewitz
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

View more
  14 in total

1.  Distinct oxidative cleavage and modification of bovine [Cu- Zn]-SOD by an ascorbic acid/Cu(II) system: Identification of novel copper binding site on SOD molecule.

Authors:  Hiroshi Uehara; Shen Luo; Baikuntha Aryal; Rodney L Levine; V Ashutosh Rao
Journal:  Free Radic Biol Med       Date:  2016-02-10       Impact factor: 7.376

Review 2.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  Engineering upper hinge improves stability and effector function of a human IgG1.

Authors:  Boxu Yan; Daniel Boyd; Timothy Kaschak; Joni Tsukuda; Amy Shen; Yuwen Lin; Shan Chung; Priyanka Gupta; Amrita Kamath; Anne Wong; Jean-Michel Vernes; Gloria Y Meng; Klara Totpal; Gabriele Schaefer; Guoying Jiang; Bartek Nogal; Craig Emery; Martin Vanderlaan; Paul Carter; Reed Harris; Ashraf Amanullah
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

Review 4.  Fragmentation of monoclonal antibodies.

Authors:  Josef Vlasak; Roxana Ionescu
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

Review 5.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 6.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

7.  Breaking the light and heavy chain linkage of human immunoglobulin G1 (IgG1) by radical reactions.

Authors:  Boxu Yan; Daniel Boyd
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 8.  Formation, reactivity, and detection of protein sulfenic acids.

Authors:  Nicholas J Kettenhofen; Matthew J Wood
Journal:  Chem Res Toxicol       Date:  2010-09-16       Impact factor: 3.739

Review 9.  Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?

Authors:  Randall J Brezski; Robert E Jordan
Journal:  MAbs       Date:  2010-05-23       Impact factor: 5.857

10.  Cysteine racemization on IgG heavy and light chains.

Authors:  Qingchun Zhang; Gregory C Flynn
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.